Target-binding molecules for conditionally activated receptor signaling

TW202631670APending Publication Date: 2026-08-01CHUGAI PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-09-05
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001070341_001
    Figure TWG2TA001070341_001
  • Figure TWG2TA001070341_002
    Figure TWG2TA001070341_002
  • Figure TWG2TA001070341_003
    Figure TWG2TA001070341_003
Patent Text Reader

Abstract

The present invention relates to one or more target-binding molecules, each comprising a binding domain [S1] and a binding domain [S2] that are each capable of binding to a scaffold protein, a binding domain [R1] that is capable of binding to a first receptor protein, and a binding domain [R2] that is capable of binding to a second receptor protein. The target-binding molecule is capable of inducing receptor signaling of a receptor complex, conditioned upon binding to a scaffold protein.
Need to check novelty before this filing date? Find Prior Art